0.3675
前日終値:
$0.3601
開ける:
$0.3643
24時間の取引高:
43,365
Relative Volume:
0.15
時価総額:
$7.56M
収益:
$301.60K
当期純損益:
$-8.22M
株価収益率:
-0.727
EPS:
-0.5055
ネットキャッシュフロー:
$-5.05M
1週間 パフォーマンス:
+5.51%
1か月 パフォーマンス:
-16.69%
6か月 パフォーマンス:
-60.83%
1年 パフォーマンス:
-77.73%
Nexalin Technology Inc Stock (NXL) Company Profile
Compare NXL vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
NXL
Nexalin Technology Inc
|
0.3675 | 7.56M | 301.60K | -8.22M | -5.05M | -0.5055 |
|
ABT
Abbott Laboratories
|
101.83 | 176.95B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
332.07 | 127.18B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.42 | 110.95B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
61.86 | 91.93B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
80.84 | 46.61B | 6.07B | 1.06B | 1.34B | 1.8063 |
Nexalin Technology Inc (NXL) 最新ニュース
Aug Gainers: Does Nexalin Technology Inc stock benefit from AI growth2026 Historical Comparison & High Conviction Buy Zone Alerts - baoquankhu1.vn
Treasury Yields: Is Nexalin Technology Inc Equity Warrant stock a good dividend stock2026 Setups & Growth Oriented Trade Recommendations - baoquankhu1.vn
Trade Recap: Why is Nexalin Technology Inc Equity Warrant stock going up2026 Technical Overview & Real-Time Buy Zone Alerts - baoquankhu1.vn
NXL PE Ratio & Valuation, Is NXL Overvalued - Intellectia AI
Nexalin Technology (NXL) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
Merger Talk: Can Nexalin Technology Inc Equity Warrant be recession proofTreasury Yields & Weekly Watchlist for Hot Stocks - baoquankhu1.vn
Wall Street Recap: Will Nexalin Technology Inc Equity Warrant outperform during market rallies2026 Highlights & Weekly High Return Opportunities - baoquankhu1.vn
Breakout Zone: Whats Nexalin Technology Inc Equity Warrants historical return2026 Market Sentiment & Risk Managed Investment Signals - baoquankhu1.vn
Fund Flows: Is Nexalin Technology Inc a turnaround story2026 Risk Factors & Fast Gain Swing Alerts - baoquankhu1.vn
Growth Value: Is Nexalin Technology Inc Equity Warrant subject to activist investor interestQuarterly Trade Report & Detailed Earnings Play Strategies - baoquankhu1.vn
Nexalin Technology Inc reports results for the quarter ended December 31Earnings Summary - tradingview.com
Nexalin Technology (NASDAQ: NXL) outlines losses, trials and U.S. FDA pathway - Stock Titan
Nexalin Technology 10-K: Revenue $0.302M, Net loss $(8.222M) - TradingView
Trading Action: Can Nexalin Technology Inc Equity Warrant outperform in the next rally2026 WrapUp & Accurate Intraday Trading Signals - baoquankhu1.vn
Nexalin Technology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Inflation Data: Can Nexalin Technology Inc Equity Warrant outperform in the next rallyQuarterly Risk Review & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Stock Market Recap: What is Nexalin Technology Inc Equity Warrants 5 year growth outlookTrade Risk Summary & Capital Protection Trading Alerts - baoquankhu1.vn
If You Invested $1,000 in Nexalin Tech (NXL) - Stock Titan
Volatility Watch: Whats next for Nexalin Technology Inc Equity Warrant stock2026 AllTime Highs & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
NXL Should I Buy - Intellectia AI
Earnings Miss: Is Nexalin Technology Inc Equity Warrant subject to activist investor interestExit Point & Technical Pattern Alert System - baoquankhu1.vn
Breakout Zone: What are analysts price targets for Nexalin Technology Inc Equity WarrantEarnings Miss & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
Revenue Check: Is Nexalin Technology Inc showing insider buying2026 Technical Patterns & Accurate Buy Signal Alerts - baoquankhu1.vn
Portfolio Shifts: Can Nexalin Technology Inc keep up with sector leadersOil Prices & Free Accurate Trade Setup Notifications - baoquankhu1.vn
S P Trends: Does Nexalin Technology Inc have consistent dividend growthEarnings Risk Summary & Weekly High Return Stock Forecasts - baoquankhu1.vn
Market Catalysts: Why is Nexalin Technology Inc Equity Warrant stock going up2026 Highlights & AI Powered Trade Plan Recommendations - baoquankhu1.vn
Smart Money: What is Nexalin Technology Inc Equity Warrants 5 year growth outlookWeekly Trade Report & Long Hold Capital Preservation Tips - baoquankhu1.vn
Nexalin Technology Inc expected to post a loss of 12 cents a shareEarnings Preview - TradingView
Short Squeeze: What is Nexalin Technology Inc Equity Warrants 5 year growth outlookWeekly Trade Summary & Fast Moving Market Watchlists - baoquankhu1.vn
Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Green Bay Press-Gazette
Short Squeeze: Will Nexalin Technology Inc. stock deliver shareholder valuePortfolio Risk Report & Precise Swing Trade Entry Alerts - Naître et grandir
Exit Recap: Can Nexalin Technology Inc. deliver consistent dividends2025 Market WrapUp & Long Hold Capital Preservation Tips - baoquankhu1.vn
Ideas Watch: Does Nexalin Technology Inc have consistent dividend growthQuarterly Investment Review & AI Based Trade Execution Alerts - baoquankhu1.vn
Market Catalysts: Whats next for Nexalin Technology Inc Equity Warrant stock2025 Big Picture & Long Hold Capital Preservation Plans - baoquankhu1.vn
NXL Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Hedge Fund Bets: What are analysts price targets for Nexalin Technology Inc Equity Warrant2025 Market WrapUp & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Nexalin Advances Pivotal HALO Clarity Trial for Insomnia - The Globe and Mail
Nexalin Announces 150-Patient Pivotal HALO Clarity Trial to Support Planned De Novo FDA Submission - TradingView
Nexalin (Nasdaq: NXL) advances pivotal HALO Clarity insomnia trial toward FDA de novo bid - Stock Titan
Nasdaq Moves: Can Nexalin Technology Inc Equity Warrant continue delivering strong returns2025 Growth vs Value & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Nexalin Launches Pivotal HALO Clarity Trial To Support Planned FDA Submission For Insomnia - Nasdaq
Nexalin announces pivotal Halo(TM) Clarity trial - marketscreener.com
Nexalin Announces Pivotal HALO™ Clarity Trial to Support Planned De Novo FDA Submission Targeting Multi-Billion-Dollar Insomnia Market - The Manila Times
Drug-free insomnia device trial targets 30 million adults - Stock Titan
EXCLUSIVE: Penny Stock Nexalin Advances Pivotal Trial Aiming To Tackle Severe Insomnia - Bitget
Nexalin Participates in and Commends Recent Congressional Momentum Supporting Deep Brain Neurostimulation Research for Veterans and Neurological Disorders - Bitget
Nexalin Technology, Inc. Applauds Bipartisan Congressional Support for Deep Brain Neurostimulation Research and Expanding Access for Veterans - Quiver Quantitative
Congress boosts brain stimulation research for veterans, with Nexalin involved - Stock Titan
NXLNexalin Tech Latest Stock News & Market Updates - Stock Titan
Can Nexalin Technology Inc. Equity Warrant be recession proofMarket Sentiment Summary & Reliable Momentum Entry Alerts - mfd.ru
Will Nexalin Technology Inc. Equity Warrant outperform during market ralliesPortfolio Value Summary & Weekly High Conviction Ideas - mfd.ru
Nexalin Technology Inc (NXL) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):